COMPLEMENT PATHWAY INHIBITOR FUSIONS AND METHODS OF USING THE SAME

METHODS OF MODULATING CIRCADIAN CLOCK GENE EXPRESSION

Composition and Use Method Therefor

METHODS OF USING ACTIVIN RECEPTOR TYPE IIB VARIANTS

GENE THERAPY METHODS FOR ARRHYTHMOGENIC CARDIOMYOPATHY

Methods and Compositions for Treatment of Angiogenic Disorders Using Anti-VEGF Agents

FORMULATIONS COMPRISING ACTRIIA POLYPEPTIDE VARIANTS

ANTAGONIST OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR USE IN THE TREATMENT OR THE PREVENTION OF SKELETAL DISORDERS LINKED WITH ABNORMAL ACTIVATION OF FGFR3

CONTACT LENSES INCLUDING MEDICAMENTS AND METHODS OF MAKING AND USING SAME INCLUDING SLOW RELEASE OF GLAUCOMA TREATING DRUGS AND COMFORT ENHANCING DRUGS

SYSTEMS AND METHODS FOR PRECISION DOSE DELIVERY, STERLIZATION, AND PACKAGING OF MEDICAL DEVICES

MICRONIZED COMPOSITIONS FOR WOUND HEALING PREPARED FROM INTACT HUMAN AMNION-CHORION TISSUE HAVING AN INTACT INTERMEDIATE SPONGY LAYER POSITIONED THERE BETWEEN

PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING RENAL CYSTIC CILIOPATHY

CASSETTES OF ANTI-COMPLEMENT COMPONENT 3 ANTIBODY, VECTORIZATION AND THERAPUTIC APPLICATION

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR ENHANCING CD8+ T CELL-DEPENDENT IMMUNE RESPONSES IN SUBJECTS SUFFERING FROM CANCER

Inhibitors of Glutathione S-Transferases (GSTS) and NAD(P)H:Quinone Oxidoreductase 1 (NQO1), Pharmaceutical Compositions, and Uses in Managing Cancer

COMPOSITIONS AND METHODS FOR TARGETING ACTIVIN SIGNALING TO TREAT CANCER

Inducing Proliferation of Cardiomyocytes and Therapeutic Uses Related Thereto

FUSION CONSTRUCTS AND METHODS OF USING THEREOF

CAPSID VARIANTS AND USES THEREOF

VEGFR FUSION PROTEIN PHARMACEUTICAL COMPOSITION

MODULATION OF WNT SIGNALLING IN OCULAR DISORDERS

METHODS FOR TREATING BLOOD LOSS CONDITIONS

ACTIVIN RECEPTOR TYPE IIA VARIANTS AND METHODS OF USE THEREOF

DISRUPTION OF EPITHELIAL BARRIERS FOR MOLECULAR DELIVERY ENHANCEMENT OR EXTRACTION OF EXTRACELLULAR FLUIDS

ANTI-PD-1 MONOCLONAL ANTIBODY, DERIVATIVE THEREOF AND USE THEREOF

FABRICATION OF PROTEIN-ENCAPSULATING MICROGELS

COMPOSITIONS AND METHODS FOR EYE DISEASES

Use of a VEGF Antagonist to Treat Angiogenic Eye Disorders

Designed Biosensors for Enhanced T Cell Therapy

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

SUSTAINED RELEASE FORMULATIONS USING NON-AQUEOUS MEMBRANE EMULSIFICATION

METHODS AND COMPOSITIONS FOR TREATING MYELOFIBROSIS

ACTIVIN RECEPTOR TYPE IIB VARIANTS AND METHODS OF USE THEREOF

MICRONIZED COMPOSITIONS FOR WOUND HEALING PREPARED FROM INTACT HUMAN AMNION-CHORION TISSUE HAVING AN INTACT INTERMEDIATE SPONGY LAYER POSITIONED THERE BETWEEN

COMPOSITIONS, METHODS AND USES OF ALPHA 1-ANTITRYPSIN FOR TREATMENT OF GRAFT VERSUS HOST DISEASE

METHOD OF TREATING PANCREATIC CANCER

Therapeutic Compositions for the Treatment of Dry Eye Disease

TARGETING NEUROPILIN 2 (NRP2) IN LETHAL PROSTATE CANCER

THERAPEUTIC USE OF P75NTR NEUROTROPHIN BINDING PROTEIN

COMPOSITIONS AND METHODS FOR DEPLETION OF DISEASED HEMATOPOIETIC STEM CELLS

POLYOMAVIRAL GENE DELIVERY VECTOR PARTICLE COMPRISING A NUCLEIC ACID SEQUENCE ENCODING A PHOSPHATASE ACTIVITY-POSSESSING POLYPEPTIDE

PHARMACEUTICAL COMPOSITION FOR TREATING AND/OR PREVENTING RENAL CYSTIC CILIOPATHY

THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF DRY EYE DISEASE

Use of a VEGF Antagonist to Treat Angiogenic Eye Disorders

METHOD FOR ENHANCING EXPRESSION OF INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IN UMBILICAL CORD MESENCHYMAL STEM CELL AND METHOD FOR OBTAINING MULTIPOTENT UMBILICAL CORD MESENCHYMAL STEM CELL

COMPOSITIONS, DEVICES, AND METHODS FOR TREATING CNS DISORDERS

GFRALPHA1-CONTAINING NEURITE OUTGROWTH PROMOTER AND PHARMACEUTICAL COMPOSITION FOR INDUCING NERVE REGENERATION

High Concentration VEGF Receptor Fusion Protein Containing Formulations

CIRCULAR RNA VACCINES AND METHODS OF USE THEREOF

MODIFIED AAV CAPSID PROTEIN AND USE THEREOF

METHODS AND PHARMACEUTICAL COMPOSITION FOR TREATING THROMBOTIC DISORDERS

THERAPEUTIC COMPOSITIONS AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY SKIN DISEASE WITH RECOMBINANT MICROORGANISMS

Advanced Avatar Dendritic Cells

FERROCHELATASE INHIBITORS AND METHODS OF USE

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

MODIFIED ACTRII PROTEINS AND METHODS OF USE THEREOF

Extended, High Dose VEGF Antagonist Regimens for Treatment of Angiogenic Eye Disorders

COMPOSITIONS COMPRISING AXITINIB AND METHODS OF TREATING OCULAR DISORDERS

TARGETED/IMMUNOMODULATORY FUSION PROTEINS AND METHODS FOR MAKING SAME

METHODS OF TREATING AGING-RELATED DISORDERS

Compositions and methods for targeted immunomodulatory antibodies and fusion proteins

Formulations for VEGF Receptor Fusion Proteins

COMBINATION THERAPY FOR TREATMENT OF CORONARY ARTERY DISEASE

FORMULATIONS COMPRISING A TRIS BUFFER AND A PROTEIN

INTERLEUKIN-10 MUTEINS AND FUSION PROTEINS THEREOF

HUMAN UMBILICAL COMPOSITIONS AND METHODS FOR DERMAL APPLICATION

BISPECIFIC CHIMERIC ANTIGEN RECEPTORS AND THERAPEUTIC USES THEREOF

METHODS OF TREATING LOCALLY ADVANCED OR METASTATIC PANCREATIC ADENOCARCINOMA USING AXL DECOY RECEPTORS AS FIRST-LINE THERAPY

AN ANTI-ANGIOGENIC AGENT AND RELATED METHODS

ANTI-ACVR2A ANTIBODIES AND USES THEREOF

INJECTION DEVICE FOR DRUG DELIVERY AND PACKAGING FOR THE INJECTION DEVICE

COMPOSITIONS AND METHODS FOR TREATING RENAL DISEASES OR CONDITIONS

Methods and Compositions for Treatment of Angiogenic Disorders Using Anti-VEGF Agents

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

METHOD FOR PROMOTING BONE GROWTH USING ACTIVIN-ACTRIIA ANTAGONISTS

Methods for Diagnosing and Treating Ischemic Eye Disease

ANTAGONIST OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR USE IN THE TREATMENT OR THE PREVENTION OF SKELETAL DISORDERS LINKED WITH ABNORMAL ACTIVATION OF FGFR3

SUSTAINABLE OCULAR CELL-MEDIATED INTRAOCULAR DELIVERY OF CELLULAR THERAPEUTICS FOR TREATMENT OF OCULAR DISEASES OR DISORDERS

Advanced avatar dendritic cells

COMPOSITIONS COMPRISING SASP MODULATORS AND SENESCENCE ATTENUATORS AND USES THEREOF FOR MODULATING CELLULAR SENESCENCE

CHIMERIC ANTIGEN RECEPTOR

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

ACTRII PROTEINS AND USES THEREOF

ACTRII PROTEINS AND USES THEREOF

FORMULATED RECEPTOR POLYPEPTIDES AND RELATED METHODS

NEURO-MESENCHYME UNITS CONTROL ILC2 AND OBESITY VIA A BRAIN-ADIPOSE CIRCUIT

Micronized compositions for wound healing prepared from intact human amnion-chorion tissue having an intact intermediate spongy layer positioned there between

TREATMENTS FOR SYSTEMIC SCLEROSIS

POLYMER PROTEIN MICROPARTICLES

METHODS OF TREATING OCULAR DISEASES USING AAV2 VARIANTS ENCODING AFLIBERCEPT

DNA STRUCTURE FOR TREATING OCULAR PATHOLOGIES

Novel Method of Treating Macular Degeneration Using Botulinum Toxin-Based Pharmaceuticals

COMPOSITIONS AND METHODS FOR TREATING SPINAL MUSCULAR ATROPHY

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

COMPOSITIONS AND METHODS OF TREATING CANCER WITH CHIMERIC ANTIGEN RECEPTORS

NOVEL FORMULATION OF FUSION PROTEIN

METHODS OF TREATING AN OCULAR DISEASE OR DISORDER

Activin receptor type IIB variants and methods of use thereof

Use of a VEGF antagonist to treat angiogenic eye disorders

SURGICAL TOOL FOR TRANSRETINAL PNEUMATIC DISPLACEMENT OF SUB-RETINAL HEMORRHAGE

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

High Concentration VEGF Receptor Fusion Protein Containing Formulations

Combination Treatment of Cancer

CONJUGATES FOR IMMUNOTHERAPY

Extended, High Dose VEGF Antagonist Regimens for Treatment of Angiogenic Eye Disorders

METHOD OF MODULATING SENSITIVITY TO TYROSINE KINASE INHIBITOR

COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING CANCER

Ocular Compositions and Methods Thereof

METHOD FOR TREATING OR PREVENTING IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY (IPCV)

SUSTAINED RELEASE FORMULATIONS USING NON-AQUEOUS EMULSIONS

COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING CANCER

TREATMENTS FOR COMPLICATIONS ASSOCIATED WITH CHRONIC LIVER DISEASE

VEGF ANTAGONIST FORMULATIONS SUITABLE FOR INTRAVITREAL ADMINISTRATION

METHODS OF TREATING LYMPHOPENIA

METHOD OF TREATING OR AMELIORATING A PATHOGENIC INFECTION BY ADMINISTERING AN INTERLEUKIN-2/TGF-BETA RECEPTOR FUSION POLYPEPTIDE

VEGFR fusion protein pharmaceutical composition

Compositions and methods for inhibiting the activity of LAR family phosphatases

STABLE PHARMACEUTICAL PREPARATION

FUSION PROTEINS AND METHODS THEREOF

Extended, High Dose VEGF Antagonist Regimens for Treatment of Angiogenic Eye Disorders

ACTIVIN-ACTRII ANTAGONISTS AND USES FOR TREATING BONE AND OTHER DISORDERS

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

FORMULATIONS COMPRISING ACTRII POLYPEPTIDE VARIANTS

OPHTHALMIC LIQUID COMPOSITION

Liquid Formulation of a VEGF Antagonist

ANTI-ANGIOGENIC GENE THERAPY WITH SOLUBLE VEGF RECEPTORS -1, -2 AND -3 TOGETHER WITH PACLITAXEL PROLONGS SURVIVAL OF MICE WITH HUMAN OVARIAN CARCINOMA

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

Bispecific chimeric antigen receptors, encoding polynucleotides and use of receptors thereof to treat cancer

NOVEL RECOMBINANT EXOSOME AND USE THEREOF

SOMATOSTATIN RECEPTOR-BASED CANCER THERAPY

TRANSFORMING GROWTH FACTOR-BETA LIGAND TRAPS FOR THE TREATMENT OF DISEASE

METHODS AND COMPOSITIONS FOR TREATING ANEMIA USING ACTRIIB LIGAND TRAPS AND MTOR INHIBITORS

Human Antibodies to GREM1

SINGLE-ARM ACTRIIA AND ACTRIIB HETEROMULTIMERS AND METHODS FOR TREATING PULMONARY HYPERTENSION

VARIANT ACTRIIB PROTEINS AND USES THEREOF

METHODS FOR TREATING ANEMIA USING AN ACTRIIB LIGAND TRAP AND FEDRATINIB

METHODS OF MAKING CHIMERIC ANTIGEN RECEPTOR-EXPRESSING CELLS

MODIFIED EPIDERMAL GROWTH FACTOR RECEPTOR PEPTIDES FOR USE IN GENETICALLY-MODIFIED CELLS

COMBINATION TREATMENT FOR CANCER BASED UPON AN ICOS ANTBODY AND A PD-L1 ANTIBODY TGF-BETS-RECEPTOR FUSION PROTEIN

ACTIVIN-ACTRII ANTAGONISTS AND USES FOR TREATING ANEMIA

LONG-ACTING VEGF INHIBITORS FOR INTRAOCULAR NEOVASCULARIZATION

Composition and method for preventing, alleviating or treating cancer

COMPOSITION FOR PREVENTING, ALLEVIATING OR TREATING CANCER

PHARMACEUTICAL PACKAGE FOR OPHTHALMIC FORMULATIONS

CHIMERIC FUSIONS BETWEEN C4-BINDING PROTEIN C-TERMINAL SEGMENT AND ANGIOPOIETIN-1 FIBRINOGEN-LIKE DOMAIN AS ANGIOPOIETIN MIMETICS AND TIE2 AGONISTS TO TREAT VASCULAR DISEASES

COMPOSITIONS COMPRISING AXITINIB AND METHODS OF TREATING OCULAR DISORDERS

METHODS OF USING ACTIVIN RECEPTOR TYPE IIB VARIANTS

ANTAGONIST OF THE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (FGFR3) FOR USE IN THE TREATMENT OR THE PREVENTION OF SKELETAL DISORDERS LINKED WITH ABNORMAL ACTIVATION OF FGFR3

Compounds for treatment of eye diseases associated with excessive vascularisation

Method for enhancing expression of insulin like growth factor 1 receptor in umbilical cord mesenchymal stem cell expressing IGF1R and method for obtaining multipotent umbilical cord mesenchymal stem cell

Inhibitors of Glutathione S-Transferases (GSTS) and NAD(P)H:Quinone Oxidoreductase 1 (NQO1), Pharmaceutical Compositions, and Uses in Managing Cancer

COMPOSITION AND USE THEREOF

IGG:TGFBETARII FUSION PROTEIN COMPOSITION

LONG-ACTING VEGF INHIBITORS FOR INTRAOCULAR NEOVASCULARIZATION

TREATMENT FOR PHYSIOLOGICAL IRON OVERLOAD

Methods for Treating Osteoarthritis

ANTI-PD-L1 ANTIGEN BINDING PROTEIN AND APPLICATION THEREOF

TREATMENT FOR AGE-RELATED MACULAR DEGENERATION (AMD)

APPLICATION OF NON-IGF1R-BINDING SUBSTANCE IN PREVENTION AND/OR TREATMENT OF INFLAMMATORY DISEASES

COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY

TREATMENTS FOR EXUDATIVE MACULOPATHIES

TRANSGENE GENETIC TAGS AND METHODS OF USE

USE OF MOG FOR PRIMING A TREATMENT FOR GLIOBLASTOMA

4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES

DEFINED COMPOSITION GENE MODIFIED T-CELL PRODUCTS

Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen species

HUMAN UMBILICAL CORD COMPOSITIONS AND METHODS FOR INTRA-ARTICULAR THERAPY

Methods Of Preventing Or Treating Fatty Degeneration Of Skeletal Muscle

METHOD FOR PRODUCING FUSION PROTEIN HAVING IGG FC DOMAIN

VACCINE FOR THE PREVENTION OF BREAST CANCER RELAPSE

REGENERATIVE BIOACTIVE SUSPENSION DERIVED FROM FRESHLY DISAGGREGATED TISSUE AND METHODS OF USE IN CLINICAL THERAPIES

Composition for treating cancer and use and medicament thereof

COMPOSITIONS DERIVED FROM HUMAN AMNION CELLS & RELATED METHODS

Compositions, formulations and methods for treating ocular diseases

Use of a VEGF antagonist to treat angiogenic eye disorders

METHODS AND COMPOSITIONS FOR TARGETING TGF-ß SIGNALING IN CD4+ HELPER T CELLS FOR CANCER IMMUNOTHERAPY

FUSION PROTEIN OF ETA ANTIBODY AND TGF-BETA TRAP AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF

Method of treating or ameliorating a pathogenic infection by administering an interleukin-2/TGF-β receptor fusion polypeptide

FABRICATION OF PROTEIN-ENCAPSULATING MICROGELS

HTRA1-BINDING AGENTS AND METHODS OF USE THEREOF

TREATMENT OF CANCERS USING sEphB4-HSA FUSION PROTEINS

Polymer protein microparticles

VACCINE FOR THE PREVENTION OF BREAST CANCER RELAPSE

METHODS FOR INCREASING RED BLOOD CELL LEVELS AND TREATING INEFFECTIVE ERYTHROPOIESIS

METHOD FOR PROMOTING BONE GROWTH USING ACTIVIN-ACTRIIA ANTAGONISTS

METHODS FOR TREATING HETEROTOPIC OSSIFICATION

COMPOSITIONS AND METHODS FOR TARGETED IMMUNOMODULATORY ANTIBODIES AND FUSION PROTEINS

SYNERGISTIC TUMOR TREATMENT WITH IL-2 AND INTEGRIN-BINDING-FC FUSION PROTEIN

Genetically Engineered Cells and Uses Thereof

Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist

Sustained release formulations using non-aqueous membrane emulsification

Advanced avatar dendritic cells

Long-acting VEGF inhibitors for intraocular neovascularization

COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR NEOVASCULARIZATION

METHODS TO ENHANCE T CELL REGENERATION

METHODS AND COMPOSITIONS FOR TREATING ULCERS

COMBINATION THERAPY FOR TREATMENT OF CORONARY ARTERY DISEASE

ANTISENSE OLIGOMERS AND USES THEREOF

Compositions and methods for targeting activin signaling to treat cancer

MODULATION OF WNT SIGNALLING IN OCULAR DISORDERS

TREATMENT OF OCULAR NEOVASCULARIZATION USING ANTI-VEGF PROTEINS

METHODS FOR TARGETED TREATMENT AND PREDICTION OF PATIENT SURVIVAL IN CANCER

Compositions comprising SASP modulators and senescence attenuators and uses thereof for modulating cellular senescence

ISOLATED GDF TRAP POLYPEPTIDE

USE OF ONCOLYTIC VIRUSES FOR THE TREATMENT OF CANCER

Compositions and methods for treating spinal muscular atrophy

Long-acting VEGF inhibitors for intraocular neovascularization

Long-acting VEGF inhibitors for intraocular neovascularization

THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF DRY EYE DISEASE

USE OF CANNABANOIDS IN THE TREATMENT OF PROLIFERATIVE DIABETIC RETINOPATHY

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR ENHANCING CD8+ T CELL-DEPENDENT IMMUNE RESPONSES IN SUBJECTS SUFFERING FROM CANCER

Methods of treating aging-related disorders

Drug regulated transgene expression

Crystalline forms of a quinazoline compound and its hydrochloride salts

LIQUID COMPOSITION COMPRISING PROTEIN

KITS AND METHODS FOR TREATING CANCERS

NANOPARTICLE COMPOSITIONS AND USES THEREOF

Fusion constructs and methods of using thereof

Combination Therapy for Cancer

Aflibercept formulations and uses thereof

METHODS AND AGENTS TO TREAT INFERTILITY IN FEMALES

TUMOR TREATMENT USING CYTOKINES AND CANCER DRUGS

Sustained release formulations using non-aqueous emulsions

Chimeric antigen receptor

VEGF Antagonist Formulations

Method for treating angiogenic eye disorders using VEGF antagonists

HCMV ENTRY INHIBITORS

TOPICAL COMPOSITION FOR IMPROVED HEALING OF OCULAR AILMENTS

ANTIANGIOGENIC CHROMANE DERIVATIVE AND USES THEREOF

METHOD AND COMPOSITIONS FOR CELLULAR IMMUNOTHERAPY

Methods for treating angiogenic eye disorders with high doses of VEGF receptor fusion proteins

FORMULATIONS COMPRISING A TRIS BUFFER AND A PROTEIN

TREATMENT OF ANEMIA DUE TO VERY LOW, LOW, OR INTERMEDIATE RISK MYELODYSPLASTIC SYNDROMES IN SUBJECTS WITH RING SIDEROBLASTS USING ACTIVIN-ACTRll LIGAND TRAPS

VEGF antagonist formulations suitable for intravitreal administration

CHIMERIC RECEPTOR POLYPEPTIDES IN COMBINATION WITH TRANS METABOLISM MOLECULES MODULATING INTRACELLULAR LACTATE CONCENTRATIONS AND THERAPEUTIC USES THEREOF

Compositions and methods of treating cancer with chimeric antigen receptors

Methods and compositions for treating myelofibrosis

FGFR REGULATION FOR THE TREATMENT OF VIRAL INFECTIONS

Compounds for treatment of eye diseases associated with excessive vascularisation

Bispecific chimeric antigen receptors, encoding polynucleotides thereof and methods of use thereof to treat disease

Soluble fibroblast growth factor receptor 3 (SFGFR3) polypeptides and uses thereof

Use of a VEGF antagonist to treat angiogenic eye disorders

Use of a VEGF antagonist to treat angiogenic eye disorders

Anti-EGFR1-PD1 targeted/immunomodulatory fusion protein

Compositions and methods for treating pulmonary hypertension

Compositions and methods for treating pulmonary hypertension

Inducing proliferation of cardiomyocytes and therapeutic uses related thereto

METHOD FOR PREDICTING THE OUTCOME OF A TREATMENT WITH AFLIBERCEPT OF A PATIENT SUSPECTED TO SUFFER FROM A CANCER BY MEASURING THE LEVEL OF A PLASMA BIOMARKER

COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING MACULAR DEGENERATION

ACTIVIN-ACTRIIA ANTAGONISTS AND USES FOR TREATING MULTIPLE MYELOMA

CD40L-Fc FUSION POLYPEPTIDES AND METHODS OF USE THEREOF

COMBINED USE OF GDF TRAPS AND ERYTHROPOIETIN RECEPTOR ACTIVATORS TO INCREASE RED BLOOD CELL LEVELS

VEGF Antagonist Formulations

VEGF Antagonist Formulations

METHODS FOR TREATING MYELODYSPLASTIC SYNDROMES AND SIDEROBLASTIC ANEMIAS

Pharmaceutical composition for preventing and treating eye diseases, containing as active ingredient, fusion protein in which tissue-penetrating peptide and anti-vascular endothelial growth factor preparation are fused

Pre-filled pharmaceutical package comprising a liquid formulation of a VEGF-antagonist

DOSING REGIMENS FOR TARGETED TGF-B INHIBITION FOR USE IN TREATING BILIARY TRACT CANCER

METHODS AND COMPOSITIONS FOR TREATING INEFFECTIVE ERYTHROPOIESIS

Compositions and methods for inhibiting the activity of LAR family phosphatases

Use of a VEGF receptor-based fusion protein antagonist to treat nonproliferative diabetic retinopathy

TREATMENT OF TRIPLE NEGATIVE BREAST CANCER WITH TARGETED TGF-B INHIBITION

IMPLANTABLE THERAPEUTIC DEVICE

SINGLE CHAIN Fc FUSION PROTEINS

Compositions of Transforming Growth Factor-Beta Type III Receptor and Uses for Ossification

Method for treating or preventing idiopathic polypoidal choroidal vasculopathy (IPCV)

THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF DRY EYE DISEASE

Production of engineered T-cells by sleeping beauty transposon coupled with methotrexate selection

NON-ANTIBODY VEGF ANTAGONISTS FOR THE TREATMENT OF NEOVASCULAR GLAUCOMA

STRETCHABLE PLUNGER ASSEMBLIES

Use of a VEGF antagonist to treat angiogenic eye disorders

Ferrochelatase inhibitors and methods of use

COMBINATION THERAPY WITH TARGETED TGF-B INHIBITION FOR TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER

ACTRIIB ANTAGONISTS AND DOSING AND USES THEREOF

Methods of treating an ocular disease or disorder

PHARMACEUTICAL COMPOSITION COMPRISING CCN5 AS ACTIVE INGREDIENT, FOR PREVENTING OR TREATING RETINAL DISEASES

TREATMENT OF STAGE III NSCLC AND MITIGATION OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH THE TREATMENT

MOLECULES, COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER

Use of a VEGF antagonist to treat angiogenic eye disorders

Citrate buffered VEGF antagonist formulations

COMBINATION TUMOR TREATMENT WITH AN INTEGRIN-BINDING-FC FUSION PROTEIN AND IMMUNE STIMULATOR

Combination of anti-HGFR antibody and HEGFR for the treatment of a tumor and/or metastasis

COMPOSITION AND METHOD OF TREATMENT FOR DRY A.M.D. (AGE RELATED MACULAR DEGENERATION)

Injection device for drug delivery and packaging for the injection device

Nucleic acids encoding p75NTR neurotrophin binding proteins

ACTIVIN RECEPTOR TYPE IIA VARIANTS AND METHODS OF USE THEREOF

METHOD OF PROMOTING BONE GROWTH BY AN ANTI-ACTRIIA ANTIBODY

Soluble fibroblast growth factor receptor 3 (FGR3) polypeptide for use in the prevention or treatment of skeletal growth retardation disorders

Soluble fibroblast growth factor receptor 3 (FGR3) polypeptide for use in the prevention or treatment of skeletal growth retardation disorders

Activin receptor type IIa variants and methods of use thereof

PD-L1 binding fibronectin type III domains

Immunoglobulin complex comprising interleukin-15

Combination of anti-FGFR4-antibody and bile acid sequestrant

Compositions and methods for treating pulmonary hypertension

Use of a VEGF antagonist to treat angiogenic eye disorders

METHODS AND COMPOSITIONS RELATING TO LUNG REPAIR

SOLUBLE FGFR3 DECOYS FOR TREATING SKELETAL GROWTH DISORDERS